Reidy J J, Limberg M, Kaufman H E
Lions Eye Research Laboratories, Louisiana State University Medical Center School of Medicine, New Orleans.
Ophthalmology. 1990 Sep;97(9):1201-3. doi: 10.1016/s0161-6420(90)32435-1.
Collagen corneal shields show promise as an alternative method of drug delivery to the eye. The authors quantified collagen shield delivery of sodium fluorescein to the aqueous humor in human volunteers using fluorophotometry. Collagen shields that had been immersed in 0.01% sodium fluorescein were applied to eyes of human volunteers. The shields delivered significantly more fluorescein to the aqueous humor at 2 and 4 hours compared with drops of the same concentration instilled every 30 minutes for 4 hours (P less than 0.0001 and P = 0.0003, respectively) or daily wear soft contact lenses presoaked in 0.01% fluorescein (P less than 0.0001 and P less than 0.0025, respectively). Collagen shields did not induce damage to the corneal epithelium over a 2-hour wearing period. These results suggest that the collagen shield may be superior to topical drops in delivering water-soluble compounds to the cornea and aqueous humor.
胶原角膜屏障有望成为一种向眼部给药的替代方法。作者使用荧光光度法对人类志愿者眼中胶原屏障向房水输送荧光素钠的情况进行了量化。将浸入0.01%荧光素钠中的胶原屏障应用于人类志愿者的眼睛。与每30分钟滴注相同浓度的溶液持续4小时(分别为P<0.0001和P = 0.0003)或每日佩戴预先浸泡在0.01%荧光素中的软性隐形眼镜(分别为P<0.0001和P<0.0025)相比,屏障在2小时和4小时时向房水输送的荧光素明显更多。在佩戴2小时的时间段内,胶原屏障未对角膜上皮造成损伤。这些结果表明,在向角膜和房水输送水溶性化合物方面,胶原屏障可能优于局部滴眼液。